檢索結果 - Juliane Manitz
- Showing 1 - 6 results of 6
-
1
-
2
Avelumab first‐line maintenance in advanced urothelial carcinoma: Complete screening for prognostic and predictive factors using machine learning in the JAVELIN Bladder 100 phase 3... 由 Juliane Manitz, Aslihan Gerhold‐Ay, Pascal Kieslich, Parantu Shah, Thomas Mrowiec, Karin Tyroller
發表在 Cancer Medicine (2024-06-01)獲取全文
Article -
3
-
4
Pharmacometric modeling and machine learning analyses of prognostic and predictive factors in the JAVELIN Gastric 100 phase III trial of avelumab 由 Nadia Terranova, Jonathan French, Haiqing Dai, Matthew Wiens, Akash Khandelwal, Ana Ruiz‐Garcia, Juliane Manitz, Anja vonHeydebreck, Mary Ruisi, Kevin Chin, Pascal Girard, Karthik Venkatakrishnan
發表在 CPT: Pharmacometrics & Systems Pharmacology (2022-03-01)獲取全文
Article -
5
Efficacy and immune-related adverse event associations in avelumab-treated patients 由 Arun Rajan, James L Gulley, Manish R Patel, Vijay Kasturi, Karen Kelly, Marcis Bajars, Andrea B Apolo, Juliane Manitz, Sandra P D’Angelo, Isabell Speit, John Warth
發表在 Journal for ImmunoTherapy of Cancer (2020-10-01)獲取全文
Article -
6
Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis 由 James L Gulley, Manish R Patel, Keun-Wook Lee, Luc Dirix, Mary Ruisi, Jeffrey R Infante, Patrick Schöffski, Alain Ravaud, Ding Wang, Andrea B Apolo, John A Ellerton, Manish Agrawal, Michael S Gordon, Raid Aljumaily, Theodore Gourdin, Matthew H Taylor, Juliane Manitz, Gregory Pennock
發表在 Journal for ImmunoTherapy of Cancer (2020-10-01)獲取全文
Article
